ETON (etonpharma.com) Earnings per share growth this year

Official company branding of Eton Corp (ETON)

Eton Pharmaceuticals specializes in the commercialization of therapies for rare endocrine pathologies, ensuring stability through niche products. The annual variable EPS reflects yield dynamics, where the value 475.30 serves as the baseline indicator. The business relies on the absolute inelasticity of demand in pediatrics and the systematic rollout of new metabolic molecules from its development portfolio.

ETON (etonpharma.com) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for etonpharma.com (ETON)

- stock value and consensus price forecast:
Basic company analysis:Eton Corp (ETON)
Manufactured products of Eton Pharmaceuticals

Stable utilization of Eton Pharmaceuticals (ETON) contract manufacturing capacities for liquid medications ensures a predictable cash flow, minimizing operational downtime. The annual EPS percentage change reflects the growth rate of net income per share relative to the previous period, allowing investors to filter out market noise and assess the business's actual resilience to volatility through this chart.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc